Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bausch & Lomb
Pharma
Bausch + Lomb CEO Brent Saunders hits the exit again
Analysts at Evercore and Leerink called the CEO transition a surprise as the eye care specialist appears to be growing on solid ground.
Angus Liu
Oct 12, 2026 10:53am
Bausch & Lomb gets FDA warning letter for contamination concerns
Sep 17, 2026 9:36am
Bausch + Lomb survey reveals low dry eye awareness
Sep 1, 2026 1:00pm
Despite trial miss, Bausch + Lomb advances combo to ph. 3
Aug 25, 2026 10:46am
Verily Me, Bausch + Lomb partner up on dry eye education
Aug 6, 2026 9:35pm
Bausch + Lomb brings glaucoma into focus with awareness push
Jan 5, 2026 12:06pm
